Study of Biological Effect of Tarceva (OSI-774) for Patients Stricken by ENT Epidermoid Carcinoma

Condition:   Head and Neck NeoplasmsIntervention:   Drug: TarcevaSponsors:   Institut Claudius Regaud;   Roche Pharma AGCompleted - verified May 2008
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials